Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma: phase III RESOLVE study-Reference-Cited by-同舟云学术

Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma: phase III RESOLVE study

Published:2021-05 Issue:5 Volume:32 Page:600-608
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Tempero M.,Oh D.-Y.,Tabernero J.,Reni M.,Van Cutsem E.,Hendifar A.,Waldschmidt D.-T.,Starling N.,Bachet J.-B.,Chang H.-M.,Maurel J.,Garcia-Carbonero R.,Lonardi S.,Coussens L.M.,Fong L.,Tsao L.C.,Cole G.,James D.,Macarulla T.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference19 articles.

1. Cancer statistics, 2019;Siegel;CA Cancer J Clin,2019

2. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial;Burris;J Clin Oncol,1997

3. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine;Von Hoff;N Engl J Med,2013

4. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer;Conroy;N Engl J Med,2011

5. Carcinoma of pancreatic body and tail: are there improvements in diagnosis and treatment modalities over the past decade?;Falconi;Dig Liver Dis,2003

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Barriers and opportunities in pancreatic cancer immunotherapy;npj Precision Oncology;2024-09-12

2. Impact of N-Terminal PEGylation on Synthesis and Purification of Peptide-Based Cancer Epitopes for Pancreatic Ductal Adenocarcinoma (PDAC);ACS Omega;2024-08-01

3. Devimistat (CPI-613) With Modified Fluorouarcil, Oxaliplatin, Irinotecan, and Leucovorin (FFX) Versus FFX for Patients With Metastatic Adenocarcinoma of the Pancreas: The Phase III AVENGER 500 Study;Journal of Clinical Oncology;2024-08-01

4. Complete response to chemotherapy in a 6-year survivor of metastatic pancreatic cancer;BMJ Case Reports;2024-07

5. Prospect of Gold Nanoparticles in Pancreatic Cancer;Pharmaceutics;2024-06-14